Curi Bio and Cook MyoSite Announce Strategic Partnership

Curi Bio, the global leader in human 3D engineered tissue platforms, has announced a strategic partnership with Cook MyoSite, a pioneer in skeletal muscle-based therapies, to develop advanced and predictive human engineered tissue models. The collaboration will focus on muscle-related diseases and metabolic disorders, including obesity and diabetes.